Havah Therapeutics Pty Ltd.
USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Havah ranks #24,453 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 2 technology areas.
- #24,453
- of 49,997 US assignees by volume
- 28th percentile
- by Innovation Score (28.6/100)
- 18.3
- avg claims per patent
- +133%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R24453 · Foreign Corporation #24,453 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #24,453/49,997
- PHOTO-FINISH Hario
- CPC-NARROW A61P · 2 areas
- INNOV-THIN 28.6/100
- CLAIMS-RICH 18.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +133% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Hario Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Havah’s 28.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Havah
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Havah Therapeutics Pty · this assignee 29
Havah Therapeutics Pty · this assignee
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Havah's Innovation Score is 28.6/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Havah?
Each dot is one of Havah’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Havah’s own 18.3 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Havah's grants concentrate
Havah Therapeutics Pty Ltd. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2019. By volume, Havah sits between Hario Co., Ltd. and Heuron Co., Ltd..
Havah's three-year grant acceleration
Havah Therapeutics Pty Ltd. shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Havah's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Hario
Hario Co., Ltd.
11 patents
- Harmar Mobility
Harmar Mobility, LLC
11 patents
- Harpoon Medical
Harpoon Medical, Inc.
11 patents
- Hatchtech Group B…
HatchTech Group B.V.
11 patents
- Heatscape com
Heatscape.com, Inc.
11 patents
- Helmerich & Payne
Helmerich & Payne, Inc.
11 patents
- Hesse
Hesse GmbH
11 patents
- Heuron
Heuron Co., Ltd.
11 patents
- Havah Therapeutic… ◀
Havah Therapeutics Pty Ltd.
11 patents
What this shows Havah holds 11 patents at rank #24,478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Havah
By rank, the assignees closest to #24,478 in granted patent volume.
- Hario Co., Ltd. #24,474 · 11 patents
- Harmar Mobility, LLC #24,475 · 11 patents
- Harpoon Medical, Inc. #24,476 · 11 patents
- HatchTech Group B.V. #24,477 · 11 patents
- Heatscape.com, Inc. #24,479 · 11 patents
- Helmerich & Payne, Inc. #24,480 · 11 patents
- Hesse GmbH #24,481 · 11 patents
- Heuron Co., Ltd. #24,482 · 11 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Havah's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Havah's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 28th percentile higher than 28% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 18.2% |
| 2019 | 1 | 9.1% |
| 2020 | 3 | 27.3% |
| 2021 | 1 | 9.1% |
| 2022 | 1 | 9.1% |
| 2024 | 2 | 18.2% |
| 2025partial year | 1 | 9.1% |
Which technologies does Havah Therapeutics Pty Ltd. patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Havah Therapeutics Pty Ltd.'s patent record in context - here's where to go next.
- Havah Therapeutics Pty Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #24,453 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Havah Therapeutics Pty Ltd. against Hario Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.